- Home
- Johnson & Johnson
Johnson & Johnson
What you need to know about Johnson & Johnson’s 2022 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Meet 7 people who inspired us in 2022
Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.
4 things we now know about hip replacement surgery
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
What happens when antibiotics stop working?
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
What are autoantibodies?
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
What you need to know about Johnson & Johnson’s 2022 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
How Johnson & Johnson is supporting mental healthcare in the Hispanic and Latino communities
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Mental Health Awareness Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.
“I’m working to develop better treatments for children with devastating diseases”
A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
Meet 3 men who’ve been on the front lines of HIV treatments for decades
Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
What you need to know about Johnson & Johnson’s 2022 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.